Ireland's Manufacturing Downturn Deepens In April

By RTTNews Staff Writer   ✉   | Published:

Ireland's manufacturing activity deteriorated further at a faster pace in April amid a sharper contraction in output and a sustained decline in new orders due to weak demand conditions, the purchasing managers' survey data from S&P Global showed on Tuesday.

The AIB Ireland manufacturing Purchasing Managers' Index , or PMI, dropped to 48.6 in April from 49.7 in March. Any reading below 50 indicates contraction in the sector.

Further, the latest contraction was the joint-strongest since a decade.

The production rate fell the fastest in five months, reflecting weaker demand conditions and, to a lesser extent, material shortages. Both domestic and foreign orders continued to decline in April.

As a result, firms reduced their purchasing activity for eight months in a row.

However, supply-side trends continued to improve in the second quarter of this year. Average lead times shortened to the greatest extent since August 2009.

On the price front, input prices fell for the first time since June 2020, largely led by moderations in raw material prices. Nonetheless, firms increased their selling prices again as they continued to pass on previous cost increases to their clients.

Looking ahead, goods producers remained upbeat about production in the next twelve months amid hopes for an eventual upturn in demand, with plans for new product development and production improvements.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
British energy major BP Plc reported Tuesday a replacement cost profit in its first quarter, compared to last year's hefty loss, while underlying replacement cost profit was lower as last year was benefited by surge in fuel prices following Russia's invasion of Ukraine. The company also announced a further $17.5 billion share buyback. BP shares were losing around 5 percent in the morning trading The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar New York -based Del Maguey Co. is recalling certain promotional ceramicware cups called copitas, citing possibility to exceed guidance levels for leachable lead by the U.S. Food and Drug Administration. Copitas are small artisan cups traditionally used for drinking mezcal, a distilled alcoholic beverage made from any type of agave.